What does this research mean for the field?

The validated differential pulse voltammetry method enables rapid and sustainable quantification of metformin and empagliflozin in plasma. Novelty: ClaimNovelty.METHODOLOGICAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To develop and validate a method for quantifying metformin and empagliflozin in plasma using differential pulse voltammetry.

February 23, 2026

Balancing performance and sustainability: a white differential pulse voltammetry method for metformin and empagliflozin in plasma

Key Points

To develop and validate a method for quantifying metformin and empagliflozin in plasma using differential pulse voltammetry.
Validated differential pulse voltammetry on a glassy carbon electrode (DPV-GCE) was used.
Samples were analyzed without modification or chromatography.
Focus on proof-of-concept for routine therapeutic monitoring.
Method demonstrated rapid and sustainable quantification of drugs in plasma.
Clinical application is currently limited to spiked samples rather than real patient samples.

Abstract

Validated DPV-GCE enables rapid, sustainable MEF/EMP quantification in plasma without modification/chromatography. Proof-of-concept for routine therapeutic monitoring; clinical translation limited by spiked (not patient) samples.

Bookmark

Cite This Study

Sattar et al. (Fri,) studied this question.

synapsesocial.com/papers/699bee1c1c6c6bad5397fcdf https://doi.org/https://doi.org/10.1080/17576180.2026.2630071

Bookmark